Abstract: The invention provides an olefin-olefinic alcohol copolymer and a preparation method thereof, said copolymer comprising a spherical and/or spherical-like polymer. The copolymer provided by the invention exhibits a good morphology and has good prospects in industrial use.

Abstract: The present invention provides a copolymer of an olefin and an unsaturated carboxylic acid or an unsaturated carboxylic acid derivative, said copolymer being a spherical and/or spherical-like polymer. The copolymer provided by the invention exhibits a good morphology and has good prospects in industrial use.

Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives of formula (I) having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Abstract: A net lamp and a decorative lamp, the net lamp including a plurality of conductive wires, a plurality of insulated wires, a plurality of lamp bodies disposed on the conductive wires, and a plurality of fasteners for fastening the conductive wires and the insulated wires; wherein the plurality of conductive wires and the plurality of insulated wires are connected to form a net-like structure by means of the plurality of fasteners. The decorative lamp includes the above described the net lamp.

Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Abstract: Systems, methods, media, and other such embodiments described herein relate to generation of routing trees. One embodiment involves accessing a circuit design comprising a source, a plurality of sinks, and a skew threshold associated with the source and the plurality of sinks. An initial routing tree is generated between the source and the plurality of sinks, and then a first intermediate point is identified between the source and the plurality of sinks. The first intermediate point may be identified based on a median location of all sinks of the plurality of sinks, or other criteria. The first intermediate point is then used for an updated routing tree. In some embodiments, a process proceeds iteratively until the skew threshold is reached or a maximum wire length is exceeded.

Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Abstract: Systems and methods for customizing and providing automated voice prompts for text displayed on a security system keypad are provided. Some methods can include receiving a security system message from a security system control panel, identifying a customized message that corresponds to the security system message, and transmitting the customized message to a user device for audible transmission of the customized message.

Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of sigma-2 receptor activity.

Abstract: Disclosed herein are systems and methods to reduce wirelength and congestion in an integrated circuit (IC) design. The systems and methods disclosed herein may be implemented during a detailed placement stage of IC design to identify and select a cell for relocation and determine an area of interest to which the cell can be relocated. The systems and methods may identify one or more potential locations within the area of interest where the cell can be relocated to, and then determine a cost based upon the wirelength and/or congestion for the selected cell, at each of the one or more potential locations. Upon determining that a potential location may have a lower cost compared to the original location of the selected cell, the systems and methods may relocate the selected cell to the potential location.

Abstract: A slim and cost effective power module solution derived from the multiple-phase buck converter technology that addresses the problems of inductor thickness and excessive magnetic material use. Such power module solution utilizes a multi-phase constant current topology and a corresponding electronic controller to provide a constant current source for various OLED lighting applications. The multi-phase constant current topology comprises two or more inductor-flyback diode feedback loops. Each inductor-flyback diode feedback loop is triggered ON and OFF out-of-phase by a current controller, which senses and estimates the average current supplied to the load, and causes the adjustments to the average current supplied to the load by controlling the ON duration of the inductor-flyback diode feedback loops.

Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Abstract: Pharmaceiiticai compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Abstract: A slim and cost effective power module solution derived from the multiple-phase buck converter technology that addresses the problems of inductor thickness and excessive magnetic material use. Such power module solution utilizes a multi-phase constant current topology and a corresponding electronic controller to provide a constant current source for various OLED lighting applications. The multi-phase constant current topology comprises two or more inductor-flyback diode feedback loops. Each inductor-flyback diode feedback loop is triggered ON and OFF out-of-phase by a current controller, which senses and estimates the average current supplied to the load, and causes the adjustments to the average current supplied to the load by controlling the ON duration of the inductor-flyback diode feedback loops.

Abstract: Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.